-
EP3918089
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3918089
| EP3918089 - METHOD FOR ISOLATING AND SEQUENCING CELL-FREE DNA [Right-click to bookmark this link] | |||
| Former [2021/49] | COMPOSITIONS AND METHODS FOR ISOLATING CELL-FREE DNA | ||
| [2023/50] | Status | Grant of patent is intended Status updated on 07.08.2024 Database last updated on 17.09.2024 | |
| Former | Examination is in progress Status updated on 24.07.2024 | ||
| Former | Grant of patent is intended Status updated on 12.05.2024 | ||
| Former | Examination is in progress Status updated on 04.11.2022 | ||
| Former | Request for examination was made Status updated on 05.11.2021 | ||
| Former | The international publication has been made Status updated on 08.08.2020 | ||
| Former | unknown Status updated on 16.03.2020 | Most recent event Tooltip | 07.08.2024 | New entry: Communication of intention to grant a patent | Applicant(s) | For all designated states Guardant Health, Inc. 3100 Hanover Street Palo Alto, CA 94304 / US | [2024/14] |
| Former [2021/49] | For all designated states Guardant Health, Inc. 505 Penobscot Drive Redwood City, CA 94063 / US | Inventor(s) | 01 /
KENNEDY, Andrew 3121 Morning Way La Jolla, California 92037 / US | 02 /
JAIMOVICH, Ariel 505 Penobscot Drive Redwood City, California 94063 / US | 03 /
SCHULTZ, Matthew 505 Penobscot Drive Redwood City, California 94063 / US | 04 /
GREENLEAF, William J. 505 Penobscot Drive Redwood City, California 94063 / US | [N/P] |
| Former [2021/49] | 01 /
KENNEDY, Andrew La Jolla, California 92037 / US | ||
| 02 /
JAIMOVICH, Ariel Redwood City, California 94063 / US | |||
| 03 /
SCHULTZ, Matthew Redwood City, California 94063 / US | |||
| 04 /
GREENLEAF, William J. Redwood City, California 94063 / US | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2021/49] | Application number, filing date | 20708962.4 | 31.01.2020 | [2021/49] | WO2020US16120 | Priority number, date | US201962799637P | 31.01.2019 Original published format: US 201962799637 P | [2021/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020160414 | Date: | 06.08.2020 | Language: | EN | [2020/32] | Type: | A1 Application with search report | No.: | EP3918089 | Date: | 08.12.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.08.2020 takes the place of the publication of the European patent application. | [2021/49] | Search report(s) | International search report - published on: | EP | 06.08.2020 | Classification | IPC: | C12Q1/6806, C12Q1/6886 | [2021/49] | CPC: |
C12Q1/6806 (EP);
C12Q1/6886 (EP,US);
C12Q2600/154 (EP,US);
C12Q2600/156 (EP);
G01N2800/50 (US)
| C-Set: |
C12Q1/6806, C12Q2535/122, C12Q2537/159, C12Q2563/131 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/49] | Title | German: | VERFAHREN ZUR ISOLIERUNG UND SEQUENZIERUNG ZELLFREIER DNA | [2023/50] | English: | METHOD FOR ISOLATING AND SEQUENCING CELL-FREE DNA | [2023/50] | French: | MÉTHODE POUR ISOLER ET SÉQUENCER DE L'ADN ACELLULAIRE | [2023/50] |
| Former [2021/49] | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ISOLIERUNG ZELLFREIER DNA | ||
| Former [2021/49] | COMPOSITIONS AND METHODS FOR ISOLATING CELL-FREE DNA | ||
| Former [2021/49] | COMPOSITIONS ET MÉTHODES POUR ISOLER DE L'ADN ACELLULAIRE | Entry into regional phase | 16.08.2021 | National basic fee paid | 16.08.2021 | Designation fee(s) paid | 16.08.2021 | Examination fee paid | Examination procedure | 16.08.2021 | Examination requested [2021/49] | 16.08.2021 | Date on which the examining division has become responsible | 01.09.2022 | Amendment by applicant (claims and/or description) | 08.11.2022 | Despatch of a communication from the examining division (Time limit: M04) | 14.03.2023 | Reply to a communication from the examining division | 12.05.2023 | Despatch of a communication from the examining division (Time limit: M04) | 15.09.2023 | Reply to a communication from the examining division | 17.11.2023 | Despatch of a communication from the examining division (Time limit: M04) | 08.03.2024 | Reply to a communication from the examining division | 13.05.2024 | Communication of intention to grant the patent | 24.07.2024 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 08.08.2024 | Communication of intention to grant the patent | Request for further processing for: | 01.09.2022 | Request for further processing filed | 01.09.2022 | Full payment received (date of receipt of payment) Request granted | 21.09.2022 | Decision despatched | Fees paid | Renewal fee | 16.08.2021 | Renewal fee patent year 03 | 27.01.2023 | Renewal fee patent year 04 | 29.01.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2017151524 (FOUND MEDICINE INC [US], et al); | [XI]WO2017190215 (UNIV HEALTH NETWORK [CA]); | [AD]WO2018119452 (GUARDANT HEALTH INC [US]); | [I]US2018305738 (KENNEDY ANDREW [US], et al); | [XP]WO2020023420 (GUARDANT HEALTH INC [US]); | by applicant | US5912148 | US6130073 | US6210891 | US6258568 | US2001053519 | US2003082600 | US6582908 | US2003152490 | US6818395 | US6833246 | US6911345 | US6969488 | US7115400 | US7169560 | US7170050 | US7282337 | US7302146 | US7313308 | US7329492 | US7476503 | US7482120 | US7501245 | US7537898 | US2011160078 | US2013244237 | US9598731 | US2017211143 | US9738894 | US9850523 | WO2018009723 | WO2018119452 | WO2019136413 |